These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 32402087)
21. Ongoing disease activity and changing categories in a long-term nordic cohort study of juvenile idiopathic arthritis. Nordal E; Zak M; Aalto K; Berntson L; Fasth A; Herlin T; Lahdenne P; Nielsen S; Straume B; Rygg M; Arthritis Rheum; 2011 Sep; 63(9):2809-18. PubMed ID: 21560116 [TBL] [Abstract][Full Text] [Related]
22. A decade of progress in juvenile idiopathic arthritis treatments and outcomes in Canada: results from ReACCh-Out and the CAPRI registry. Nguyen K; Barsalou J; Basodan D; Batthish M; Benseler SM; Berard RA; Blanchette N; Boire G; Bolaria R; Bruns A; Cabral DA; Cameron B; Campillo S; Cellucci T; Chan M; Chédeville G; Chetaille AL; Chhabra A; Couture J; Dancey P; De Bruycker JJ; Demirkaya E; Dhalla M; Duffy CM; Feldman BM; Feldman DE; Gerschman T; Haddad E; Heale L; Herrington J; Houghton K; Huber AM; Human A; Johnson N; Jurencak R; Lang B; Larché M; Laxer RM; LeBlanc CM; Lee JJY; Levy DM; Lim L; Lim LSH; Luca N; McGrath T; McMillan T; Miettunen PM; Morishita KA; Ng HY; Oen K; Park J; Petty RE; Proulx-Gauthier JP; Ramsey S; Roth J; Rosenberg AM; Rozenblyum E; Rumsey DG; Schmeling H; Schneider R; Scuccimarri R; Shiff NJ; Silverman E; Soon G; Spiegel L; Stringer E; Tam H; Tse SM; Tucker LB; Turvey S; Twilt M; Duffy KW; Yeung RSM; Guzman J Rheumatology (Oxford); 2024 Sep; 63(SI2):SI173-SI179. PubMed ID: 37851400 [TBL] [Abstract][Full Text] [Related]
23. Trends in prescription of biological agents and outcomes of juvenile idiopathic arthritis: results of the Dutch national Arthritis and Biologics in Children Register. Otten MH; Anink J; Prince FH; Twilt M; Vastert SJ; ten Cate R; Hoppenreijs EP; Armbrust W; Gorter SL; van Pelt PA; Kamphuis SS; Dolman KM; Swart JF; van den Berg JM; Koopman-Keemink Y; van Rossum MA; Wulffraat NM; van Suijlekom-Smit LW Ann Rheum Dis; 2015 Jul; 74(7):1379-86. PubMed ID: 24641940 [TBL] [Abstract][Full Text] [Related]
24. Clinical remission and subsequent relapse in patients with juvenile idiopathic arthritis: predictive factors according to therapeutic approach. Castillo-Vilella M; Giménez N; Tandaipan JL; Quintana S; Modesto C Pediatr Rheumatol Online J; 2021 Aug; 19(1):130. PubMed ID: 34419078 [TBL] [Abstract][Full Text] [Related]
25. Clinical Outcome and Long-term Remission in JIA. Glerup M; Herlin T; Twilt M Curr Rheumatol Rep; 2017 Nov; 19(12):75. PubMed ID: 29101579 [TBL] [Abstract][Full Text] [Related]
26. A new Canadian inception cohort for juvenile idiopathic arthritis: The Canadian Alliance of Pediatric Rheumatology Investigators Registry. Batthish M; Berard R; Cabral D; Bolaria R; Chédeville G; Duffy C; Gerhold K; Gerschman T; Huber A; Proulx-Gauthier JP; Rosenberg A; Rumsey D; Schmeling H; Shiff N; Soon G; Bruns A; Tucker L; Guzman J; Rheumatology (Oxford); 2020 Oct; 59(10):2796-2805. PubMed ID: 32044978 [TBL] [Abstract][Full Text] [Related]
27. Clinical and MRI outcome of cervical spine lesions in children with juvenile idiopathic arthritis treated with anti-TNFα drugs early in disease course. Ključevšek D; Emeršič N; Toplak N; Avčin T Pediatr Rheumatol Online J; 2017 May; 15(1):38. PubMed ID: 28506237 [TBL] [Abstract][Full Text] [Related]
28. [Guidelines on biologic drugs for the treatment of children with juvenile idiopathic arthritis (JIA)]. Bukovac LT; Vidović M; Lamot L; Perica M; Harjacek M; Reumatizam; 2013; 60(1):57-66. PubMed ID: 24003687 [TBL] [Abstract][Full Text] [Related]
29. Predictors and long-term outcome in Greek adults with juvenile idiopathic arthritis: a 17-year continuous follow-up study. Dimopoulou D; Trachana M; Pratsidou-Gertsi P; Sidiropoulos P; Kanakoudi-Tsakalidou F; Dimitroulas T; Garyfallos A Rheumatology (Oxford); 2017 Nov; 56(11):1928-1938. PubMed ID: 29088453 [TBL] [Abstract][Full Text] [Related]
30. Subtype frequencies, demographic features, and remission rates in juvenile idiopathic arthritis - 265 cases from a Turkish center. Çakan M; Aktay-Ayaz N; Keskindemirci G; Ekinci DY; Karadağ ŞG Turk J Pediatr; 2017; 59(5):548-554. PubMed ID: 29745116 [TBL] [Abstract][Full Text] [Related]
32. Juvenile Idiopathic Arthritis: Oligoarthritis and Polyarthritis. Crayne CB; Beukelman T Pediatr Clin North Am; 2018 Aug; 65(4):657-674. PubMed ID: 30031492 [TBL] [Abstract][Full Text] [Related]
33. Juvenile idiopathic arthritis in the biologic era: predictors of the disease progression and need for early introduction of biologic treatment. Nalbanti P; Kanakoudi-Tsakalidou F; Trachana M; Pratsidou-Gertsi P; Farmaki E; Bamidis P; Papachristou F Rheumatol Int; 2018 Jul; 38(7):1241-1250. PubMed ID: 29845429 [TBL] [Abstract][Full Text] [Related]
34. Ankle arthritis predicts polyarticular disease course and unfavourable outcome in children with juvenile idiopathic arthritis. Esbjörnsson AC; Aalto K; Broström EW; Fasth A; Herlin T; Nielsen S; Nordal E; Peltoniemi S; Rygg M; Zak M; Berntson L; Clin Exp Rheumatol; 2015; 33(5):751-7. PubMed ID: 26213158 [TBL] [Abstract][Full Text] [Related]
35. Three- and five-year outcomes of an inception cohort of Australian children with juvenile idiopathic arthritis. Tiller G; Hernandez BL; Buckle J; Allen R; Munro J; Gowdie P; Cox A; Akikusa J Int J Rheum Dis; 2024 May; 27(5):e15189. PubMed ID: 38769844 [TBL] [Abstract][Full Text] [Related]
36. Etanercept treatment for extended oligoarticular juvenile idiopathic arthritis, enthesitis-related arthritis, or psoriatic arthritis: 6-year efficacy and safety data from an open-label trial. Foeldvari I; Constantin T; Vojinović J; Horneff G; Chasnyk V; Dehoorne J; Panaviene V; Sušić G; Stanevicha V; Kobusinska K; Zuber Z; Dobrzyniecka B; Nikishina I; Bader-Meunier B; Breda L; Doležalová P; Job-Deslandre C; Rumba-Rozenfelde I; Wulffraat N; Pedersen RD; Bukowski JF; Vlahos B; Martini A; Ruperto N; Arthritis Res Ther; 2019 May; 21(1):125. PubMed ID: 31122296 [TBL] [Abstract][Full Text] [Related]
37. Two-year outcome of juvenile idiopathic arthritis in current daily practice: what can we tell our patients? Anink J; Dolman KM; Merlijn van den Berg J; van Veenendaal M; Kuijpers TW; van Rossum MA Clin Exp Rheumatol; 2012; 30(6):972-8. PubMed ID: 23190600 [TBL] [Abstract][Full Text] [Related]
38. Early outcomes and improvement of patients with juvenile idiopathic arthritis enrolled in a Canadian multicenter inception cohort. Oen K; Duffy CM; Tse SM; Ramsey S; Ellsworth J; Chédeville G; Chetaille AL; Saint-Cyr C; Cabral DA; Spiegel LR; Schneider R; Lang B; Huber AM; Dancey P; Silverman E; Rosenberg AM; Cameron B; Johnson N; Dorval J; Scuccimarri R; Campillo S; Petty RE; Duffy KN; Boire G; Haddad E; Houghton K; Laxer R; Turvey SE; Miettunen P; Gross K; Guzman J; Benseler S; Feldman BM; Espinosa V; Yeung RS; Tucker L Arthritis Care Res (Hoboken); 2010 Apr; 62(4):527-36. PubMed ID: 20391508 [TBL] [Abstract][Full Text] [Related]
39. Accuracy of Wallace criteria for clinical remission in juvenile idiopathic arthritis: a cohort study of 761 consecutive cases. Lurati A; Salmaso A; Gerloni V; Gattinara M; Fantini F J Rheumatol; 2009 Jul; 36(7):1532-5. PubMed ID: 19487265 [TBL] [Abstract][Full Text] [Related]
40. Patterns of clinical remission in select categories of juvenile idiopathic arthritis. Wallace CA; Huang B; Bandeira M; Ravelli A; Giannini EH Arthritis Rheum; 2005 Nov; 52(11):3554-62. PubMed ID: 16255044 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]